Virtual Didactic - Pharmacotherapy in mTBI presented by Mary Alexis Iaccarino, MD-Virtual Didactic - Pharmacotherapy in mTBI Led by Mary Alexis Iaccarino, MD

Virtual Didactic - Pharmacotherapy in mTBI Led by Mary Alexis Iaccarino, MD

Video Transcription

Video Summary

The video summary discusses the use of medication in the treatment of mild traumatic brain injury (TBI). The speaker, Alexis Icarino, presents information on the off-label use of medication for the physical, emotional, and cognitive symptoms associated with mild TBI. Attention is given to the prevalence of mild TBI and the importance of behavioral and environmental adaptations as the mainstay of treatment. The speaker highlights the lack of evidence-based pharmacotherapies for mild TBI and emphasizes the use of medication for symptom management rather than a cure. Medications such as analgesics, triptans, tricyclic antidepressants, SSRIs, SNRIs, and stimulants are discussed in relation to specific symptoms and conditions. The speaker also addresses side effects, dosing, and the need for adequate trials of medication before determining efficacy. The use of medication in conjunction with psychotherapy and cognitive rehabilitation is emphasized. The summary concludes by encouraging further research and collaboration in the field of pharmacotherapy for mild TBI.

Keywords

medication

mild traumatic brain injury

off-label use

symptom management

analgesics

triptans

SSRIs

stimulants

cognitive rehabilitation